Biotech Legislation and Advocacy

Guest host Paul Matteis, Biotech Analyst at Stifel, joins Daphne Zohar, Brad Loncar, Josh Schimmer, Dawn Bell and Bruce Booth on this week’s episode of Biotech Hangout to discuss market sentiment, biotech’s bear market, CTAD and World Sleep meetings and Roche to acquire Telavant ($7.1B). The hosts also cover industry issues such as the Orphan Cures Act, More Transparency Act, PRVs and more after Daphne attended meetings with senators and congressmen in DC. Additionally, they talk about the second largest A round of funding in 2023 from Aiolos Bio ($245M) plus OrbiMed’s $4.3B raise, CARGO Therapeutics’ IPO and >40 biotechs exploring strategic alternatives. Other topics include CMS expanding Medicare coverage to Alzheimer’s PET scan testing, Senator Bernie Sanders to investigate NIH licensing practices, delays in cancer care and Novartis regulatory filing pushed after data disappoints at ESMO. *This episode aired on October 27, 2023